Vicky A Appleman

6PUBLICATIONS
124CO-AUTHORS
Radiation therapyAllergyBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.

Benjamin T Cooper, Wade T Iams, David B Page

|Feb 07, 2025
Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500.

Vicky A Appleman, Atsushi Matsuda, Michelle L Ganno

|Jul 13, 2023
Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles.

Pere Dosta, Alexander M Cryer, Michelle Z Dion

|Mar 16, 2023
TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies.

Elizabeth Carideo Cunniff, Yosuke Sato, Doanh Mai

|Mar 07, 2023
Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma.

Alan T Yeo, Rushil Shah, Konstantinos Aliazis

|Jun 09, 2022
Activation of Tumor-Cell STING Primes NK-Cell Therapy.

Erik H Knelson, Elena V Ivanova, Mubin Tarannum

Pageof 1